Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olmesartan and amlodipine in stage 1 and 2 hypertension
NCT00527514Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olmesartan in hypertension (HTN), sponsored by Daiichi Sankyo Co., Ltd.. Started Sep 2007; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00527514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00527514.